SAMANTHA ROZARIO: Open Payments
NPI 1679928402 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 62 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $425 |
| Lundbeck LLC | 6 | $169 |
| Axsome Therapeutics, Inc. | 8 | $144 |
| UCB, Inc. | 5 | $124 |
| Merz Pharmaceuticals, LLC | 4 | $96 |
| PFIZER INC. | 3 | $71 |
| TG Therapeutics, Inc. | 2 | $55 |
| Eisai Inc. | 2 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: QULIPTA, UBRELVY, VYEPTI, Symbravo, Xeomin, Nayzilam, NURTEC ODT, BRIUMVI.
Industry payments across NC — which companies pay providers there.
